Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. J Clin Oncol. 2020 11 01; 38(31):3685-3697.

View in: PubMed

subject areas

Age Factors
Chromosome Aberrations
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 11
Clinical Trials as Topic
Diploidy
Gene Amplification
Genomics
Humans
Infant
Neoplasm Staging
Neuroblastoma
N-Myc Proto-Oncogene Protein
Prognosis
Survival Rate

authors with profiles

Susan L. Cohn